Cargando…

Structural and Functional RNA Motifs of SARS-CoV-2 and Influenza A Virus as a Target of Viral Inhibitors

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 pandemic, whereas the influenza A virus (IAV) causes seasonal epidemics and occasional pandemics. Both viruses lead to widespread infection and death. SARS-CoV-2 and the influenza virus are RNA viruses. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Szczesniak, Izabela, Baliga-Gil, Agnieszka, Jarmolowicz, Aleksandra, Soszynska-Jozwiak, Marta, Kierzek, Elzbieta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860923/
https://www.ncbi.nlm.nih.gov/pubmed/36674746
http://dx.doi.org/10.3390/ijms24021232
_version_ 1784874712606703616
author Szczesniak, Izabela
Baliga-Gil, Agnieszka
Jarmolowicz, Aleksandra
Soszynska-Jozwiak, Marta
Kierzek, Elzbieta
author_facet Szczesniak, Izabela
Baliga-Gil, Agnieszka
Jarmolowicz, Aleksandra
Soszynska-Jozwiak, Marta
Kierzek, Elzbieta
author_sort Szczesniak, Izabela
collection PubMed
description Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 pandemic, whereas the influenza A virus (IAV) causes seasonal epidemics and occasional pandemics. Both viruses lead to widespread infection and death. SARS-CoV-2 and the influenza virus are RNA viruses. The SARS-CoV-2 genome is an approximately 30 kb, positive sense, 5′ capped single-stranded RNA molecule. The influenza A virus genome possesses eight single-stranded negative-sense segments. The RNA secondary structure in the untranslated and coding regions is crucial in the viral replication cycle. The secondary structure within the RNA of SARS-CoV-2 and the influenza virus has been intensively studied. Because the whole of the SARS-CoV-2 and influenza virus replication cycles are dependent on RNA with no DNA intermediate, the RNA is a natural and promising target for the development of inhibitors. There are a lot of RNA-targeting strategies for regulating pathogenic RNA, such as small interfering RNA for RNA interference, antisense oligonucleotides, catalytic nucleic acids, and small molecules. In this review, we summarized the knowledge about the inhibition of SARS-CoV-2 and influenza A virus propagation by targeting their RNA secondary structure.
format Online
Article
Text
id pubmed-9860923
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98609232023-01-22 Structural and Functional RNA Motifs of SARS-CoV-2 and Influenza A Virus as a Target of Viral Inhibitors Szczesniak, Izabela Baliga-Gil, Agnieszka Jarmolowicz, Aleksandra Soszynska-Jozwiak, Marta Kierzek, Elzbieta Int J Mol Sci Review Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 pandemic, whereas the influenza A virus (IAV) causes seasonal epidemics and occasional pandemics. Both viruses lead to widespread infection and death. SARS-CoV-2 and the influenza virus are RNA viruses. The SARS-CoV-2 genome is an approximately 30 kb, positive sense, 5′ capped single-stranded RNA molecule. The influenza A virus genome possesses eight single-stranded negative-sense segments. The RNA secondary structure in the untranslated and coding regions is crucial in the viral replication cycle. The secondary structure within the RNA of SARS-CoV-2 and the influenza virus has been intensively studied. Because the whole of the SARS-CoV-2 and influenza virus replication cycles are dependent on RNA with no DNA intermediate, the RNA is a natural and promising target for the development of inhibitors. There are a lot of RNA-targeting strategies for regulating pathogenic RNA, such as small interfering RNA for RNA interference, antisense oligonucleotides, catalytic nucleic acids, and small molecules. In this review, we summarized the knowledge about the inhibition of SARS-CoV-2 and influenza A virus propagation by targeting their RNA secondary structure. MDPI 2023-01-08 /pmc/articles/PMC9860923/ /pubmed/36674746 http://dx.doi.org/10.3390/ijms24021232 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Szczesniak, Izabela
Baliga-Gil, Agnieszka
Jarmolowicz, Aleksandra
Soszynska-Jozwiak, Marta
Kierzek, Elzbieta
Structural and Functional RNA Motifs of SARS-CoV-2 and Influenza A Virus as a Target of Viral Inhibitors
title Structural and Functional RNA Motifs of SARS-CoV-2 and Influenza A Virus as a Target of Viral Inhibitors
title_full Structural and Functional RNA Motifs of SARS-CoV-2 and Influenza A Virus as a Target of Viral Inhibitors
title_fullStr Structural and Functional RNA Motifs of SARS-CoV-2 and Influenza A Virus as a Target of Viral Inhibitors
title_full_unstemmed Structural and Functional RNA Motifs of SARS-CoV-2 and Influenza A Virus as a Target of Viral Inhibitors
title_short Structural and Functional RNA Motifs of SARS-CoV-2 and Influenza A Virus as a Target of Viral Inhibitors
title_sort structural and functional rna motifs of sars-cov-2 and influenza a virus as a target of viral inhibitors
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860923/
https://www.ncbi.nlm.nih.gov/pubmed/36674746
http://dx.doi.org/10.3390/ijms24021232
work_keys_str_mv AT szczesniakizabela structuralandfunctionalrnamotifsofsarscov2andinfluenzaavirusasatargetofviralinhibitors
AT baligagilagnieszka structuralandfunctionalrnamotifsofsarscov2andinfluenzaavirusasatargetofviralinhibitors
AT jarmolowiczaleksandra structuralandfunctionalrnamotifsofsarscov2andinfluenzaavirusasatargetofviralinhibitors
AT soszynskajozwiakmarta structuralandfunctionalrnamotifsofsarscov2andinfluenzaavirusasatargetofviralinhibitors
AT kierzekelzbieta structuralandfunctionalrnamotifsofsarscov2andinfluenzaavirusasatargetofviralinhibitors